Costimulatory TNFR family members in control of viral infection: Outstanding questions

Seminars in Immunology

Volumn 26, Issue 3, 2014, Pages 210-219

  Mbanwi, Achire N ^a   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

4 1BB; CD27; Cytomegalovirus; GITR; Influenza; LCMV; OX40; T cell; Vaccinia

Indexed keywords

ACTIN BINDING PROTEIN; BETA CATENIN; CD134 ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CD27 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2; MESSENGER RNA; OX40 LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR 7; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE OVEREXPRESSION; HUMAN; HUMAN HERPESVIRUS 8; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; INFECTION CONTROL; INFLUENZA; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSIENT EXPRESSION; VIRAL CLEARANCE; VIRUS INFECTION; VIRUS LOAD; AGONISTS; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; T LYMPHOCYTE; VIROLOGY; VIRUS DISEASES;

ANIMALS; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84903983977     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.05.001     Document Type: Review

References (128)

1. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
2. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 12:492-499.
3. Wherry E.J., Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004, 78:5535-5545.
4. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity. Nat Rev Immunol 2003, 3:609-620.
5. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009, 9:271-285.
6. Snell L.M., Lin G.H., McPherson A.J., Moraes T.J., Watts T.H. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol Rev 2011, 244:197-217.
7. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005, 23:23-68.
8. Wortzman M.E., Clouthier D.L., McPherson A.J., Lin G.H., Watts T.H. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections. Immunol Rev 2013, 255:125-148.
9. Karin M., Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol Rev 2009, 228:225-240.
10. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27:693-733.
11. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 2010, 28:57-78.
12. Nolte M.A., van Olffen R.W., van Gisbergen K.P., van Lier R.A. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009, 229:216-231.
13. Clouthier D.L., Watts T.H. Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection. Cytokine Growth Factor Rev 2014, 25:91-106.
14. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006, 12:48-54.
15. Homann D. Immunocytotherapy. Curr Top Microbiol Immunol 2002, 263:43-65.
16. Fuse S., Bellfy S., Yagita H., Usherwood E.J. CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J Immunol 2007, 178:5227-5236.
17. Lin G.H., Sedgmen B.J., Moraes T.J., Snell L.M., Topham D.J., Watts T.H. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J Immunol 2009, 182:934-947.
18. Zhao Y., Croft M. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8T cells. Immunol Lett 2012, 141:220-226.
19. Boettler T., Moeckel F., Cheng Y., Heeg M., Salek-Ardakani S., Crotty S., et al. OX40 facilitates control of a persistent virus infection. PLoS Pathog 2012, 8:e1002913.
20. Wang C., McPherson A.J., Jones R.B., Kawamura K.S., Lin G.H., Lang P.A., et al. Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J Exp Med 2012, 209:77-91.
21. Bertram E.M., Dawicki W., Sedgmen B., Bramson J.L., Lynch D.H., Watts T.H. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8T cell response to influenza in vivo. J Immunol 2004, 172:981-988.
22. Halstead E.S., Mueller Y.M., Altman J.D., Katsikis P.D. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol 2002, 3:536-541.
23. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997, 186:47-55.
24. Melero I., Shuford W.W., Newby S.A., Aruffo A., Ledbetter J.A., Hellstrom K.E., et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997, 3:682-685.
25. McPherson A.J., Snell L.M., Mak T.W., Watts T.H. Opposing roles for TRAF1 in the alternative versus classical NF-kappaB pathway in T cells. J Biol Chem 2012, 287:23010-23019.
26. Sabbagh L., Pulle G., Liu Y., Tsitsikov E.N., Watts T.H. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J Immunol 2008, 180:8093-8101.
27. Hendriks J., Xiao Y., Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 2003, 198:1369-1380.
28. Baars P.A., Sierro S., Arens R., Tesselaar K., Hooibrink B., Klenerman P., et al. Properties of murine (CD8+)CD27-T cells. Eur J Immunol 2005, 35:3131-3141.
29. Welten S.P., Redeker A., Franken K.L., Benedict C.A., Yagita H., Wensveen F.M., et al. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J Virol 2013, 87:6851-6865.
30. Kuka M., Munitic I., Giardino Torchia M.L., Ashwell J.D. CD70 is downregulated by interaction with CD27. J Immunol 2013.
31. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8:379-385.
32. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15:801-812.
33. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003, 4:49-54.
34. Matter M., Odermatt B., Yagita H., Nuoffer J.M., Ochsenbein A.F. Elimination of chronic viral infection by blocking CD27 signaling. The Journal of experimental medicine 2006, 203:2145-2155.
35. van Gisbergen K.P., van Olffen R.W., van Beek J., van der Sluijs K.F., Arens R., Nolte M.A., et al. Protective CD8T cell memory is impaired during chronic CD70-driven costimulation. J Immunol 2009, 182:5352-5362.
36. Widney D., Gundapp G., Said J.W., van der Meijden M., Bonavida B., Demidem A., et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 1999, 93:114-123.
37. Suvas S., Kim B., Sarangi P.P., Tone M., Waldmann H., Rouse B.T. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. J Virol 2005, 79:11935-11942.
38. Snell L.M., McPherson A.J., Lin G.H., Sakaguchi S., Pandolfi P.P., Riccardi C., et al. CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J Immunol 2010, 185:7223-7234.
39. Pollok K.E., Kim Y.-J., Zhou Z., Hurtado J., Kim K.K., Pickard R.T., et al. Inducible T cell antigen 4-1BB: analysis of expression and function. J Immunol 1993, 150:771-781.
40. Bertram E.M., Lau P., Watts T.H. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol 2002, 168:3777-3785.
41. Lin G.H., Edele F., Mbanwi A.N., Wortzman M.E., Snell L.M., Vidric M., et al. Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8+ memory T cells in the bone marrow. Eur J Immunol 2012, 42:2861-2874.
42. Humphreys I.R., Lee S.W., Jones M., Loewendorf A., Gostick E., Price D.A., et al. Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol 2010, 40:2762-2768.
43. Zhao Y., Tahiliani V., Salek-Ardakani S., Croft M. Targeting 4-1BB (CD137) to enhance CD8T cell responses with poxviruses and viral antigens. Front Immunol 2012, 3:332.
44. van Gisbergen K.P., Klarenbeek P.L., Kragten N.A., Unger P.P., Nieuwenhuis M.B., Wensveen F.M., et al. The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants. Immunity 2011, 35:97-108.
45. Ballesteros-Tato A., Leon B., Lund F.E., Randall T.D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010, 11:216-224.
46. Munitic I., Kuka M., Allam A., Scoville J.P., Ashwell J.D. CD70 deficiency impairs effector CD8T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. J Immunol 2013, 190:1169-1179.
47. Schildknecht A., Miescher I., Yagita H., van den Broek M. Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur J Immunol 2007, 37:716-728.
48. Taraban V.Y., Rowley T.F., Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8T cell priming by CD40-licensed APCs. J Immunol 2004, 173:6542-6546.
49. Kopf M., Ruedl C., Schmitz N., Gallimore A., Lefrang K., Ecabert B., et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999, 11:699-708.
50. Dawicki W., Bertram E.M., Sharpe A.H., Watts T.H. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J Immunol 2004, 173:5944-5951.
51. Salek-Ardakani S., Moutaftsi M., Crotty S., Sette A., Croft M. OX40 drives protective vaccinia virus-specific CD8T cells. J Immunol 2008, 181:7969-7976.
52. Salek-Ardakani S., Flynn R., Arens R., Yagita H., Smith G.L., Borst J., et al. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Investig 2011, 121:296-307.
53. Wang C., Lin G.H., McPherson A.J., Watts T.H. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 2009, 229:192-215.
54. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004, 34:613-622.
55. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16:311-323.
56. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002, 3:135-142.
57. Stephens G.L., McHugh R.S., Whitters M.J., Young D.A., Luxenberg D., Carreno B.M., et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004, 173:5008-5020.
58. Boettler T., Choi Y.S., Salek-Ardakani S., Cheng Y., Moeckel F., Croft M., et al. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4T cells into the effector lineage by upregulating Blimp-1. J Immunol 2013, 191:5026-5035.
59. Salek-Ardakani S., Croft M. Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity. J Interferon Cytokine Res 2010, 30:205-218.
60. Zhang B., Maris C.H., Foell J., Whitmire J., Niu L., Song J., et al. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 2007, 117:3029-3041.
61. Zhang B., Zhang Y., Niu L., Vella A.T., Mittler R.S. Dendritic cells and Stat3 are essential for CD137-induced CD8T cell activation-induced cell death. J Immunol 2010, 184:4770-4778.
62. Cole S.L., Benam K.H., McMichael A.J., Ho L.P. Involvement of the 4-1BB/4-1BBL pathway in control of monocyte numbers by invariant NKT cells. J Immunol 2014, 192:3898-3907.
63. Diana J., Griseri T., Lagaye S., Beaudoin L., Autrusseau E., Gautron A.S., et al. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 2009, 30:289-299.
64. Melero I., Hirschhorn-Cymerman D., Morales-Kastresana A., Sanmamed M.F., Wolchok J.D. Agonist antibodies to TNFR molecules that costimulate T and NK cells. Clin Cancer Res 2013, 19:1044-1053.
65. Jang Y.S., Kang W., Chang D.Y., Sung P.S., Park B.C., Yoo S.H., et al. CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-gamma secretion. Clin Immunol 2013, 149:379-387.
66. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012, 481:394-398.
67. Lang P.A., Lang K.S., Xu H.C., Grusdat M., Parish I.A., Recher M., et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci U S A 2012, 109:1210-1215.
68. Zhou G., Juang S.W., Kane K.P. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol 2013, 43:929-938.
69. Cabal-Hierro L., Lazo P.S. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012, 24:1297-1305.
70. Ha H., Han D., Choi Y. TRAF-mediated TNFR-family signaling. Curr Protoc Immunol 2009, Chapter 11:Unit11.19D.
71. Xie P. TRAF molecules in cell signaling and in human diseases. J Mol Signal 2013, 8:7.
72. Silke J., Brink R. Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ 2010, 17:35-45.
73. Kawamata S., Hori T., Imura A., Takaori-Kondo A., Uchiyama T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation. J Biol Chem 1998, 273:5808-5814.
74. Akiba H., Nakano H., Nishinaka S., Shindo M., Kobata T., Atsuta M., et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 1998, 273:13353-13358.
75. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev 1998, 12:2821-2830.
76. Gravestein L.A., Amsen D., Boes M., Calvo C.R., Kruisbeek A.M., Borst J. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol 1998, 28:2208-2216.
77. Nakano H., Sakon S., Koseki H., Takemori T., Tada K., Matsumoto M., et al. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A 1999, 96:9803-9808.
78. Esparza E.M., Lindsten T., Stockhausen J.M., Arch R.H. Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells. J Biol Chem 2006, 281:8559-8564.
79. Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci U S A 2005, 108:2874-2879.
80. So T., Soroosh P., Eun S.Y., Altman A., Croft M. Antigen-independent signalosome of CARMA1, PKCtheta, and TNF receptor-associated factor 2 (TRAF2) determines NF-kappaB signaling in T cells. Proc Natl Acad Sci U S A 2011, 108:2903-2908.
81. Zheng C., Kabaleeswaran V., Wang Y., Cheng G., Wu H. Crystal structures of the TRAF2:cIAP2 and the TRAF1:TRAF2:cIAP2 complexes: affinity, specificity, and regulation. Mol Cell 2010, 38:101-113.
82. Sabbagh L., Andreeva D., Laramee G.D., Oussa N.A., Lew D., Bisson N., et al. Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells. J Leukoc Biol 2013, 93:713-721.
83. So T., Croft M. Regulation of PI-3-kinase and Akt signaling in T lymphocytes and other cells by TNFR family molecules. Front Immunol 2013, 4:139.
84. Song J., Salek-Ardakani S., Rogers P.R., Cheng M., Van Parijs L., Croft M. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol 2004, 5:150-158.
85. So T., Choi H., Croft M. OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol 2011, 186:3547-3555.
86. Lee do Y., Choi B.K., Lee D.G., Kim Y.H., Kim C.H., Lee S.J., et al. 4-1BB signaling activates the T cell factor 1 effector/beta-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8(+) T cells. PLoS ONE 2013, 8:e69677.
87. Jeannet G., Boudousquie C., Gardiol N., Kang J., Huelsken J., Held W. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc Natl Acad Sci U S A 2010, 107:9777-9782.
88. Zhao D.M., Yu S., Zhou X., Haring J.S., Held W., Badovinac V.P., et al. Constitutive activation of Wnt signaling favors generation of memory CD8T cells. J Immunol 2010, 184:1191-1199.
89. Zhou X., Yu S., Zhao D.M., Harty J.T., Badovinac V.P., Xue H.H. Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity 2010, 33:229-240.
90. Peperzak V., Veraar E.A., Keller A.M., Xiao Y., Borst J. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation. J Immunol 2010, 185:6670-6678.
91. Peperzak V., Veraar E.A., Xiao Y., Babala N., Thiadens K., Brugmans M., et al. CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool. J Immunol 2013, 191:3025-3036.
92. Peperzak V., Xiao Y., Veraar E.A., Borst J. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Investig 2010, 120:168-178.
93. Eissner G., Kolch W., Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine & Growth Factor Reviews 2004, 15:353-366.
94. Sun M., Fink P.J. A new class of reverse signaling costimulators belongs to the TNF family. J Immunol 2007, 179:4307-4312.
95. Watts A.D., Hunt N.H., Wanigasekara Y., Bloomfield G., Wallach D., Roufogalis B.D., et al. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J 1999, 18:2119-2126.
96. Sun M., Lee S., Karray S., Levi-Strauss M., Ames K.T., Fink P.J. Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. J Immunol 2007, 179:5639-5643.
97. Kang Y.J., Kim S.O., Shimada S., Otsuka M., Seit-Nebi A., Kwon B.S., et al. Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol 2007, 8:601-609.
98. Ma J., Bang B.R., Lu J., Eun S.Y., Otsuka M., Croft M., et al. The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation. Sci Signal 2013, 6:ra87.
99. Bae J.S., Choi J.K., Moon J.H., Kim E.C., Croft M., Lee H.W. Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells. Cell Signal 2012, 24:2227-2236.
100. Lee H.S., Park S.Y., Lee H.W., Choi H.S. Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage. J Cell Biochem 2004, 92:481-490.
101. Arens R., Nolte M.A., Tesselaar K., Heemskerk B., Reedquist K.A., van Lier R.A., et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol 2004, 173:3901-3908.
102. van Montfrans J.M., Hoepelman A.I., Otto S., van Gijn M., van de Corput L., de Weger R.A., et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129:787-793. e786.
103. Salzer E., Daschkey S., Choo S., Gombert M., Santos-Valente E., Ginzel S., et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2013, 98:473-478.
104. Byun M., Ma C.S., Akcay A., Pedergnana V., Palendira U., Myoung J., et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med 2013, 210:1743-1759.
105. Cerhan J.R., Ansell S.M., Fredericksen Z.S., Kay N.E., Liebow M., Call T.G., et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007, 110:4455-4463.
106. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4:e278.
107. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007, 357:1199-1209.
108. Fraser H.B., Xie X. Common polymorpic transcript variation in human disesase. Genome Res 2009, 19:567-575. Epub 2009 Feb 2. 10.1101/gr.083477.108.
109. Taylor P.C., Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:578-582.
110. Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013, 13:227-242.
111. Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012, 12:252-264.
112. Penaloza-MacMaster P., Ur Rasheed A., Iyer S.S., Yagita H., Blazar B.R., Ahmed R. Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice. J Virol 2011, 85:6168-6174.
113. De Milito A., Morch C., Sonnerborg A., Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001, 15:957-964.
114. Wolthers K.C., Otto S.A., Lens S.M., Kolbach D.N., van Lier R.A., Miedema F., et al. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells. Eur J Immunol 1996, 26:1700-1706.
115. Wolthers K.C., Otto S.A., Lens S.M., Van Lier R.A., Miedema F., Meyaard L. Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70. AIDS Res Hum Retroviruses 1997, 13:1023-1029.
116. Vezys V., Penaloza-MacMaster P., Barber D.L., Ha S.J., Konieczny B., Freeman G.J., et al. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection. J Immunol 2011, 187:1634-1642.
117. Hirao L.A., Hokey D.A., Morrow M.P., Jure-Kunkel M.N., Weiner D.B. Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge. PLoS ONE 2011, 6:e24250.
118. Niu L., Strahotin S., Hewes B., Zhang B., Zhang Y., Archer D., et al. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol 2007, 178:4194-4213.
119. Zhu Y., Zhu G., Luo L., Flies A.S., Chen L. CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 2007, 109:4882-4889.
120. Lee S.W., Salek-Ardakani S., Mittler R.S., Croft M. Hypercostimulation through 4-1BB distorts homeostasis of immune cells. J Immunol 2009, 182:6753-6762.
121. Curti B.D., Kovacsovics-Bankowski M., Morris N., Walker E., Chisholm L., Floyd K., et al. OX40 is a potent immune-stimulating target in late-stage cancer patients. Cancer Res 2013, 73:7189-7198.
122. Humphreys I.R., Walzl G., Edwards L., Rae A., Hill S., Hussell T. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 2003, 198:1237-1242.
123. Dittmer U., He H., Messer R.J., Schimmer S., Olbrich A.R., Ohlen C., et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004, 20:293-303.
124. He H., Messer R.J., Sakaguchi S., Yang G., Robertson S.J., Hasenkrug K.J. Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. J Virol 2004, 78:11641-11647.
125. La S., Kim E., Kwon B. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med 2005, 37:193-198.
126. Saoulli K., Lee S.Y., Cannons J.L., Yeh W.C., Santana A., Goldstein M.D., et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998, 187:1849-1862.
127. Wang C., Wen T., Routy J.P., Bernard N.F., Sekaly R.P., Watts T.H. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8T cells. J Immunol 2007, 179:8252-8263.
128. Lee H.W., Park S.J., Choi B.K., Kim H.H., Nam K.O., Kwon B.S. 4-1BB promotes the survival of CD8(+) T lymphocytes by increasing expression of Bcl-x(L) and Bfl-1. J Immunol 2002, 169:4882-4888.